Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine whether treatment with valsartan will have
beneficial effect in early hypertrophic cardiomyopathy (HCM) by assessing many domains that
reflect myocardial structure, function and biochemistry.